Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Salbutamol to Prevent Atelectasis in Diabetics
NCT07591558Phase 1Not yet recruiting
- Sponsor
- King Abdullah University Hospital
- Start
- Jun 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of salbutamol in atelectasis (4 arms), sponsored by King Abdullah University Hospital. Primary endpoints: Postoperative atelectasis assessed by vital signs at 5 months, Postoperative atelectasis assessed by x-ray at 5 months and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
atelectasis
Beyond the preview
Go deeper on NCT07591558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07591558.